GeoVax Labs, Inc. (GOVX)
NASDAQ·Healthcare·Biotechnology
$1.10
-0.90%
Mkt Cap $1.95M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 2, 2026 | $1.00M | — | — | -$4.71 | -$2.29 | +51.35% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$6.00 | -$7.75 | -29.17% | — | — |
| Q3 2025 Jul 28, 2025 | $776.08K | $852.28K | +9.82% | -$0.41 | -$0.35 | +14.63% | — | — |
| Q2 2025 May 1, 2025 | $366.67K | $1.64M | +346.41% | -$0.59 | -$0.45 | +23.73% | — | — |
| Q1 2025 Mar 27, 2025 | $2.38M | $864.41K | -63.68% | -$0.79 | -$0.30 | +62.03% | — | — |
| Q4 2024 Nov 12, 2024 | $920.00K | $2.79M | +203.20% | -$1.29 | -$0.91 | +29.46% | — | — |
| Q3 2024 Aug 6, 2024 | — | $300.68K | — | -$2.57 | -$1.99 | +22.57% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$5.56 | -$2.47 | +55.58% | — | — |
| Q1 2024 Feb 29, 2024 | — | — | — | -$2.78 | -$13.60 | -389.21% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$2.55 | -$4.80 | -88.24% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$2.40 | -$3.30 | -37.50% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$2.85 | -$2.25 | +21.05% | — | — |
| Q1 2023 Mar 8, 2023 | — | — | — | -$0.20 | -$2.24 | -1020.00% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$1.80 | -$2.55 | -41.67% | — | — |
| Q3 2022 Aug 3, 2022 | — | — | — | -$0.32 | -$2.70 | -743.75% | — | — |
| Q2 2022 Apr 27, 2022 | — | $81.53K | — | -$0.31 | -$5.10 | -1545.16% | — | — |
| Q1 2022 Mar 9, 2022 | — | $164.96K | — | -$0.40 | -$33.58 | -8295.00% | — | — |
| Q4 2021 Nov 11, 2021 | — | $30.41K | — | -$0.37 | -$4.65 | -1156.76% | — | — |
| Q3 2021 Aug 11, 2021 | $110.00K | $79.71K | -27.54% | -$0.43 | -$3.15 | -632.56% | — | — |
| Q2 2021 May 6, 2021 | — | $110.42K | — | — | -$4.35 | — | — | — |